Our partnership offer

We are an experienced LNP and RNA technology company dedicated to professionally partnering with pharma and biotech with an established interest in nucleic acid therapeutics or vaccines. Our expert team supports start-up, early-stage, and late-stage projects by using our proprietary platforms across RNA chemistry, LNP formulation, and Process Technology, to drive new pipeline development or resolve manufacturing challenges for our partners.

Why partner with us

Flexible partnership

  • Support from design, candidate designation, clinical development to regulatory approval
  • From single indications to comprehensive pipeline development

Expert development

  • Dedicated teams committed to meeting your project deadlines
  • Seamless transition through all development

Integrated offering

  • In-house in-depth chemistry, formulation and manufacturing expertise
  • Single resource for accelerated delivery,
    no need for multiple partners
etherna image

Comprehensive range of
technology platforms

We offer partnering around LNP formulation and mRNA chemistry.

  • Innovative, differentiated lipid formulations enable targeted delivery and tailored biodistribution with preclinical demonstration of superiority to competing LNP. Platforms contain lipid formulations with immune activating, silent, and suppressing characteristics.
  • Differentiated and tailored mRNA capabilities to achieve optimal protein expression: sequence optimization, UTR screening, optimized IVT & purification processes leading to highly expressing, ultra-pure RNA.
  • Co-development of customized LNPs for a specific payload and application combining etherna’s expertise, suite of experimental tools, and proprietary ionizable lipid libraries with your disease and target knowledge.

To drive discovery and solve challenges for our partners, enabling them to deliver cost-effective,
differentiated, and efficacious RNA therapeutics.

What our customers say
Contact us

Contact us with any queries or for pricing information.